We are live on
!
Find out more
AIM
Aigen Investment Management Portfolio holdings
AUM
$389M
1-Year Est. Return
16.77%
This Fund
S&P 500
This Quarter
Est. Return
+28.83%
1 Year Est. Return
+16.77%
3 Year Est. Return
+38.84%
5 Year Est. Return
+26.96%
10 Year Est. Return
–
AUM
$779M
AUM Growth
+$26.2M
(+3.5%)
Cap. Flow
-$94.9M
Cap. Flow
% of AUM
-12.17%
Top 10 Holdings %
Top 10 Hldgs %
8.33%
Holding
1,483
New
237
Increased
357
Reduced
183
Closed
706
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$5.97M |
| 2 |
Delta Air Lines
DAL
|
+$4.91M |
| 3 |
VeriSign
VRSN
|
+$4.72M |
| 4 |
Armstrong World Industries
AWI
|
+$3.93M |
| 5 |
Devon Energy
DVN
|
+$3.86M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$12.6M |
| 2 |
Microsoft
MSFT
|
+$9.18M |
| 3 |
Duke Energy
DUK
|
+$7.4M |
| 4 |
Nucor
NUE
|
+$6.45M |
| 5 |
Costco
COST
|
+$5.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.65% |
| 2 | Healthcare | 15.12% |
| 3 | Technology | 15.02% |
| 4 | Consumer Discretionary | 12.92% |
| 5 | Industrials | 11.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVOP
676
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $230K | 0.03% |
10,069
-12,905
| -56% | -$257K |
|
677
Coherent
COHR
$65B
| $224K | 0.03% |
+4,746
| New | +$188K |
|
678
Protagonist Therapeutics
PTGX
$9.63B
| $224K | 0.03% |
+12,689
| New | +$159K |
|
679
Ultrapar
UGP
$6.49B
| $224K | 0.03% |
+65,931
| New | +$194K |
|
680
Kontoor Brands
KTB
$4.26B
| $223K | 0.03% |
+12,502
| New | +$223K |
|
|
OSB
681
DELISTED
Norbord Inc.
OSB
| $223K | 0.03% |
9,770
+5,535
| +131% | +$95.2K |
|
|
DCOM
682
DELISTED
Dime Community Bancshares
DCOM
| $223K | 0.03% |
16,272
+8,509
| +110% | +$123K |
|
683
E.W. Scripps
SSP
$311M
| $222K | 0.03% |
+25,398
| New | +$204K |
|
684
Corbus Pharmaceuticals
CRBP
$177M
| $221K | 0.03% |
+876
| New | +$177K |
|
685
ICF International
ICFI
$1.66B
| $221K | 0.03% |
3,407
+3,389
| +18,828% | +$222K |
|
686
Anterix
ATEX
$1.81B
| $220K | 0.03% |
+4,860
| New | +$248K |
|
687
First Commonwealth Financial
FCF
$2.17B
| $220K | 0.03% |
+26,537
| New | +$224K |
|
688
Capital Southwest
CSWC
$1.6B
| $219K | 0.03% |
+16,265
| New | +$210K |
|
689
Halozyme
HALO
$12.3B
| $219K | 0.03% |
8,162
+5,205
| +176% | +$117K |
|
690
World Acceptance Corp
WRLD
$876M
| $219K | 0.03% |
3,348
-103
| -3% | -$6.44K |
|
691
Signet Jewelers
SIG
$3.68B
| $217K | 0.03% |
21,164
-91,477
| -81% | -$904K |
|
692
Iron Mountain
IRM
$36.4B
| $215K | 0.03% |
+8,250
| New | +$208K |
|
|
UNIT
693
Uniti Group
UNIT
$2.29B
| $215K | 0.03% |
+22,953
| New | +$172K |
|
694
Veracyte
VCYT
$3.73B
| $215K | 0.03% |
8,316
+5,045
| +154% | +$126K |
|
|
LDL
695
DELISTED
Lydall, Inc.
LDL
| $214K | 0.03% |
15,782
+8,888
| +129% | +$98.3K |
|
696
Ironwood Pharmaceuticals
IRWD
$676M
| $212K | 0.03% |
20,581
-47,837
| -70% | -$490K |
|
697
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$20B
| $212K | 0.03% |
+36,936
| New | +$172K |
|
|
OBSV
698
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $212K | 0.03% |
+35,977
| New | +$136K |
|
|
LCI
699
DELISTED
Lannett Company, Inc.
LCI
| $212K | 0.03% |
7,296
+7,067
| +3,086% | +$220K |
|
700
Colliers International
CIGI
$5.14B
| $211K | 0.03% |
+3,686
| New | +$197K |
|
Similar funds
SA
WCM
PFPGI
PG
SI
TCM
HBWM
DAM
Aigen Investment Management's Q2 2020 Portfolio in Review
As of Q2 2020, Aigen Investment Management held 1,483 positions worth $779M, up 3.5% from $753M the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
Aigen Investment Management withdrew a net $94.9M in Q2 2020, closing 706 positions and reducing 183 holdings. Its most notable exit was Microsoft, an estimated $9.18M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Aigen Investment Management opened a new position in Berkshire Hathaway Class B worth $5.84M.
- Aigen Investment Management's largest Q2 2020 buy was Berkshire Hathaway Class B: 32,702 shares worth $5.84M.
- Aigen Investment Management added most to Delta Air Lines in Q2 2020, an estimated $4.91M increase.
- Aigen Investment Management's biggest Q2 2020 reduction was Thermo Fisher Scientific, cutting an estimated $12.6M.
- Aigen Investment Management fully exited Microsoft in Q2 2020, selling an estimated $9.18M.
- Aigen Investment Management's ten largest holdings make up 8.3% of its $779M portfolio in Q2 2020.
- Aigen Investment Management opened 237 new positions and closed 706 in Q2 2020.
- Aigen Investment Management's portfolio value rose 3.5% quarter-over-quarter to $779M.
Based on Aigen Investment Management's 13F filing for Q2 2020, filed 10 Aug 2020.